July 2020

August 07, 2020

Several recent studies presented at the virtual SGO 2020 Annual Meeting on Women’s Cancer looked into veliparib, a potential anticancer PARP inhibitor, for treatment of various types of ovarian cancer.

August 07, 2020

The clinical trial of teclistamab sought to identify a recommended phase 2 dose for patients with RRMM, with multiple IV doses and priming doses explored.

August 06, 2020

A recent study evaluated the efficacy of venetoclax monotherapy in participants with relapsed or refractory chronic lymphocytic leukemia.

August 01, 2020

As the most accessible member of the health care team, the pharmacist can provide patients with cancer with the information and support necessary to get through what might be the most challenging time of their lives.

July 31, 2020

“These new therapies allow for treatment without some of the traditional chemotherapy agents.”

July 31, 2020

A fully human monoclonal antibody, cemiplimab targets the immune checkpoint receptor PD-1 on T cells, blocking cancer cells from using the PD-1 pathway to suppress T-cell activation.

July 30, 2020

Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.

July 30, 2020

The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.

July 29, 2020

These study results were announced by Eisai and Merck during the 2020 American Society of Clinical Oncology Virtual Scientific Program, May 29-31.

July 29, 2020

As clinicians, we must first understand the unique challenges that a patient is facing and then tailor our support to address their specific needs.

July 29, 2020

Pharmacists can deliver value-based oncology services as an integral part of the health care team to improve patient outcomes.

July 29, 2020

Sarcomas account for about 1% of all adult cancers and 15% of all pediatric cancers.

July 28, 2020

Many pharmacies may be missing significant, profitable opportunities...via generic pharmaceuticals.

July 28, 2020

The investigators found that patients with preexisting neutropenia could be managed on venetoclax, although use of G-CSF would likely also be required in conjunction with the treatment.

July 27, 2020

Following initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).

July 26, 2020

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.

July 25, 2020

Meaningful breakthrough therapies are receiving accelerated approval based on evidence of impact on a surrogate end point rather than evidence of impact on the actual clinical benefit for which the drug is intended.

July 23, 2020

The selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.

July 19, 2020

Results of the COVID-19 and Cancer Consortium cohort study were presented during the 2020 American Society of Clinical Virtual Scientific Program.

July 18, 2020

Directions in Oncology PharmacyTM provides insight into how specialty pharmacies can improve transitional care during the COVID-19 pandemic.